ARCHIVES

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 18 No. 38 | October 2, 1992

Download PDF Visit The Full Archive

Related Articles

Cancer Letter Takes Two Weeks Off

August 28, 1987

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

NIH Tells Grant Applicants One Resubmission Is Enough.

October 24, 2008

In Brief: Senate Subcommittee Includes $2.7 Billion Increase for NIH in Budget Bill Markup

May 12, 2000

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002